Researchers anticipated rapamycin would enhance the effects of working out, while also initiating health improvements of its ...
Rakovina Therapeutics Inc. (TSX-V: RKV; FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, today announced the ...
The FDA has granted Priority Review of Celcuity’s New Drug Application (“NDA”) for gedatolisib in patients with HR+/HER2-/ PIK3CA wild-type (“WT”) ABC and assigned a Prescription Drug User Fee Act ...
Scientists are uncovering how exercise fine-tunes powerful molecular pathways like AKT, mTOR, AMPK, and FoxO to protect muscle, boost metabolism, and slow aging. These pathways control whether muscle ...
Muscles age differently than you think. Discover the science behind the aging muscle paradox—and how exercise can help you ...
NATICK, MA, UNITED STATES, April 22, 2026 /EINPresswire.com/ -- NeuroDex and Stanford Researchers Publish First ...
A clinical trial to reverse age-related vision conditions using stem cell treatment could finally deliver on the promise of a ...
Kazia Therapeutics' lead asset, Paxalisib, showed stronger concurrent-control survival data in GBM, but FDA accelerated ...
Brain organoids reveal that two genetic mutations in DEPDC5 drive epilepsy, disrupting early brain development, and causing ...
Breast cancer is one of the most common malignancies worldwide, and mutations in the PI3K/AKT/mTOR (PAM) signaling pathway ...
Relative to routine stenting, drug-eluting balloon revascularization with as-needed stenting produced similarly low target ...